|
Re: twice weekly aspirin use may decrease bc survivor's risk of metastasis by 62-71%
Hi Lani,
Nice find. I checked the JCO website and the full text of this one seems to be freely available (although sometimes websites recognise my computer, so I am not entirely sure).
Anyway, what puzzles me about this article is that it says in the full text that ER-negative and ER-positive seem to benefit, but when I look at the confidence intervals, all of the statistically significant benefits seem to be for ER-positive. Also, the article claims that all levels benefit, but it seems statistically significant for just stages I and II.
Still, for early stages and ER-positive this looks brilliant.
I would like to know your interpretation.
Best wishes,
Christine MH-UK
|
Hybrid Mode
